Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-26T13:09:54.781Z Has data issue: false hasContentIssue false
  • English
  • Français

Introduction to Neurotherapeutics and Neuropsychopharmacology

Published online by Cambridge University Press:  15 February 2006

Jeffrey L. Cummings
Jeffrey L. Cummings
Affiliation:
Department of Neurology and Psychiatry & Biobehavioral Sciences, Davids Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Neurotherapeuticspsychotropicsclinical trialsdrug developmentPhase II, Phase III
Type
Review Article
Information
Progress in Neurotherapeutics and Neuropsychopharmacology , Volume 1 , Issue 1 , January 2006 , pp. 1 - 12
Copyright
© 2006 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cummings, J.L. (2000). Cholinesterase inhibitors: a new class of psychotropic compounds. American Journal of Psychiatry, 157, 4–15.Google Scholar
Cummings, J.L. (2003). Toward a molecular neuropsychiatry of neurodegenerative disease. Annals of Neurology, 54, 147–154.Google Scholar
Cummings, J.L. (2004). Alzheimer's disease. New England Journal of Medicine, 351, 56–67.Google Scholar
Emre, M., Aarsland, D., Albanese, A., et al. (2004). Rivastigmine for dementia associated with Parkinson's disease. New England Journal of Medicine, 351, 2509–2518.Google Scholar
Jacobs, B.L., Praag, H.V., Gage, F.H., et al. (2000). Adult brian neurogenesis and psychiatry: a novel theory of depression. Molecular Psychiatry, 5, 262–269.Google Scholar
Klunk, W.E., Engler, H., Nordberg, A., et al. (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Annals of Neurology, 55, 306–319.Google Scholar
Lee, C.J., Lee, L.H., Lu, C., et al. (2003). Development and Evaluation of Drugs (2nd edn.). CRC Press, Boca Raton, Florida.
Ng, R. (2004). Drugs from Discovery to Approval. Wiley-Liss, Hoboken, New Jersey.